BOCA RATON, FL--(Marketwire - June 18, 2008) - Vicor Technologies, Inc. (OTCBB: VCRT), reviewed strategies and developments to (i) commercialize its patented device, the PD2i Cardiac Analyzer, for risk stratification of patients for Sudden Cardiac Death (SCD); (ii) its collaboration with the U.S. Army to assess severity of injury, and probability of survival, for critically injured combat casualties and critically ill civilian patients and (iii) other milestones at its Annual Meeting of Stockholders today in Boca Raton, Florida.
